A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer
| Status: | Archived |
|---|---|
| Conditions: | Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | September 2000 |
| End Date: | December 2013 |
A Phase 1 Multiple Ascending Dose Study of BMS-833923 in Subjects With Advanced or Metastatic Solid Tumors
The purpose of this study is to determine the safety of BMS-833923 (XL139) in patients with
advanced or metastatic cancers and determine the recommended phase 2 dose range and schedule
We found this trial at
4
sites
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials